{"DataElement":{"publicId":"3919111","version":"1","preferredName":"Disease or Disorder Status Lymphoma Type","preferredDefinition":"A description of the lymphoma disease status.","longName":"2512861v1.0:2950686v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2950686","version":"1.1","preferredName":"Lymphoma Status Type","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"2950686v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not assessed","valueDescription":"Not Assessed","ValueMeaning":{"publicId":"2688820","version":"1","preferredName":"Not Assessed","longName":"2688820","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3CA061-0C4D-3BF6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDBD5DC2-8F16-A31D-E040-BB89AD43497E","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"ONEDATA","dateModified":"2013-12-17","deletedIndicator":"No"},{"value":"No response / stable disease","valueDescription":"No response / stable disease","ValueMeaning":{"publicId":"3345200","version":"1","preferredName":"No response / stable disease","longName":"3345200","preferredDefinition":"Less than 50% reduction in greatest diameter of all sites of known disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61A3632-728C-944C-E040-BB89AD434FF1","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDBD5DC2-8F2A-A31D-E040-BB89AD43497E","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"ONEDATA","dateModified":"2013-12-17","deletedIndicator":"No"},{"value":"Relapse / progressive disease","valueDescription":"Relapse / progressive disease","ValueMeaning":{"publicId":"3345203","version":"1","preferredName":"Relapse / progressive disease","longName":"3345203","preferredDefinition":"Increase in size of known disease, or new sites of disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B61A3632-72F4-944C-E040-BB89AD434FF1","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDBD5DC2-8F3E-A31D-E040-BB89AD43497E","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"ONEDATA","dateModified":"2013-12-17","deletedIndicator":"No"},{"value":"Not tested / Unknown","valueDescription":"Not Done Or Unknown","ValueMeaning":{"publicId":"3263661","version":"1","preferredName":"Not Done Or Unknown","longName":"3263661","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or completed.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB461F5D-3F06-78CA-E040-BB89AD434E2B","latestVersionIndicator":"Yes","beginDate":"2011-08-24","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDBD5DC2-8F48-A31D-E040-BB89AD43497E","beginDate":"2010-06-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"ONEDATA","dateModified":"2013-12-17","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"Recurrent Disease","ValueMeaning":{"publicId":"3828963","version":"1","preferredName":"Recurrent Disease","longName":"3828963","preferredDefinition":"The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BCE-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEC37A50-1F05-1F20-E040-BB89AD4338BE","beginDate":"2013-12-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-30","modifiedBy":"ONEDATA","dateModified":"2013-12-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32AFFDD-3D5D-6C7D-E040-BB89AD431DC1","beginDate":"2014-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"},{"value":"Complete remission (CR)","valueDescription":"Complete remission","ValueMeaning":{"publicId":"4187631","version":"1","preferredName":"Complete remission","longName":"4187631","preferredDefinition":"Complete disappearance of all known disease. For typically FDG-avid lymphoma, a post-treatment residual mass of any size is permitted as long as it is PET negative. For variably FDG-avid lymphomas, all lymph nodes and nodal masses must have regressed via CT to <1.5 cm (for nodes >1.5 cm before therapy) or <1 cm (for nodes 1.1 to 1.5 cm before therapy).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3B5BB57-C8A0-C38E-E040-BB89AD430A94","latestVersionIndicator":"Yes","beginDate":"2014-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CA67-C38E-E040-BB89AD430A94","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"},{"value":"Complete remission undetermined (CRU)","valueDescription":"Complete remission undetermined","ValueMeaning":{"publicId":"3113416","version":"1","preferredName":"Complete remission undetermined","longName":"3113416","preferredDefinition":"Complete disappearance of all known disease for greater than or equal to four weeks, with the exception of persistent scan abnormalitites of unknown significance.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A31591-6D96-AE55-E040-BB89AD432CE8","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CA7B-C38E-E040-BB89AD430A94","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"},{"value":"Continued complete remission (CCR)","valueDescription":"Continue Complete Remission","ValueMeaning":{"publicId":"3091231","version":"1","preferredName":"Continue Complete Remission","longName":"3091231","preferredDefinition":"Existing in time or space without stop or interruption.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continue","conceptCode":"C53279","definition":"Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"871DA0BF-2DEE-5ECF-E040-BB89AD43243F","latestVersionIndicator":"Yes","beginDate":"2010-05-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CA8F-C38E-E040-BB89AD430A94","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"},{"value":"Partial remission (PR)","valueDescription":"Partial remission","ValueMeaning":{"publicId":"4012012","version":"1","preferredName":"Partial remission","longName":"4012012","preferredDefinition":"Greater than or equal to 50% reductions in greatest diameter of up to six largest dominant nodes or nodal masses and no new sites. For typically FDG-avid lymphomas, post-treatment PET should be positive in at least one site. For variably PET-avid lymphoma, use CT criteria.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDBD0140-EE57-852D-E040-BB89AD4364A9","latestVersionIndicator":"Yes","beginDate":"2013-12-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CAA3-C38E-E040-BB89AD430A94","beginDate":"2009-10-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"},{"value":"Progressive disease (PD)","valueDescription":"Progressive disease (PD)","ValueMeaning":{"publicId":"4187632","version":"1","preferredName":"Progressive disease (PD)","longName":"4187632","preferredDefinition":"Increase by >50% of previously involved sites from nadir or any new lesion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3B5BB57-C8E0-C38E-E040-BB89AD430A94","latestVersionIndicator":"Yes","beginDate":"2014-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CAB7-C38E-E040-BB89AD430A94","beginDate":"2013-12-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"},{"value":"Stable disease (SD)","valueDescription":"Stable disease (SD)","ValueMeaning":{"publicId":"4187633","version":"1","preferredName":"Stable disease (SD)","longName":"4187633","preferredDefinition":"Failure to attain CR, PR, or PD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3B5BB57-C902-C38E-E040-BB89AD430A94","latestVersionIndicator":"Yes","beginDate":"2014-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3B5BB57-CACB-C38E-E040-BB89AD430A94","beginDate":"2013-12-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-03","modifiedBy":"ONEDATA","dateModified":"2014-03-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2955416","version":"1","preferredName":"Lymphoma Status Type","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C3208:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7678F018-36E0-2680-E040-BB89AD4335E1","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDBD5DC2-8EEB-A31D-E040-BB89AD43497E","latestVersionIndicator":"Yes","beginDate":"2013-12-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-17","modifiedBy":"NYCHM","dateModified":"2017-02-27","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"xlp_post_tx_status_lympho","type":"NINDS Alt Name","context":"NHLBI"},{"name":"LYMpost_lym_dis_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpost_assess_lym_alt_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the disease status?","type":"Preferred Question Text","description":"What is the disease status?","url":null,"context":"NHLBI"},{"name":"What is the current disease status?","type":"Application Standard Question Text","description":"What is the current disease status?","url":null,"context":"NHLBI"},{"name":"Specify status of lymphoma","type":"Alternate Question Text","description":"Specify status of lymphoma","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E87D5AD9-D730-60B0-E040-BB89AD4376F2","latestVersionIndicator":"Yes","beginDate":"2013-10-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-10-11","modifiedBy":"NYCHM","dateModified":"2017-02-27","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}